WHAN IN PHARM CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,830 KRW | -0.29% |
|
+1.77% | -8.05% |
| 2023 | Whan In Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2015 | Whanin Pharmaceutical Co. Ltd.(KOSE:A016580) added to Russell Global Index | CI |
Whan In Pharm Co.,Ltd. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Companyâs products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The Company also involves in the real estate rental business.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13,830
KRW
Average target price
21,000
KRW
Spread / Average Target
+51.84%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.05% | 153M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- A016580 Stock
- Funds and ETFs Whan In Pharm Co.,Ltd.
